Regulation of cell survival by atypical protein kinase C isozymes

Advances in Enzyme Regulation

Volumn 43, Issue 1, 2003, Pages 213-228

  Grunicke, Hans H ^a   Spitaler, Martin ^a,b   Mwanjewe, James ^a,c   Schwaiger, Wolfgang ^a   Jenny, Marcel ^a   Ueberall, Florian ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b Lymphocyte Activation Laboratory   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0038378166     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(02)00032-8     Document Type: Conference Paper

References (62)

1. Aguirre-Ghiso JA, Frankel P, Farias EF, Lu Z, Jiang H, Olsen A, Feig LA, Kier Joffe EB, Foster DA. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene 1999;18:4718-25.
2. Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y, Barlow C, Baltimore D, Wynshaw-Boris A, Kastan MB, Wang JY. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 1997;387:516-9.
3. Berra E, Diasz-Meco MT, Dominguez I, Municio MM, Sanz L, Lozano J, Chapkin RS, Moscat J. Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell 1993;74:555-63.
4. Blume-Jensen P, Janknecht R, Hunter T. The kit receptor promotes cell survival via activation of PI3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr Biol 1998;8:779-82.
5. Buchner K. The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus. J Cancer Res Clin Oncol 2000;126:1-11.
6. Cilby WA, Lewis KA, Lilly KK, Kaufmann SH. S phase and G2 arrests induced by topoisomerase I poison are dependent on ATR kinase function. J Biol Chem 2002;277:1599-606.
7. D'Armours D, Jackson StP. The MREM complex: at the crossroads of DNA repair and checkpoint signalling. Nat Rev Mol Cell Biol 2002;3:317-27.
8. Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 1990;247:824-30.
9. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-41.
10. Diaz-Meco MT, Dominiquez I, Sanz L, Dent P, Lozano J, Municio MM, Berra E, Hay RT, Sturgill TW, Moscat J. ζPKC induces phosphorylation and inactivation of IkBα in vitro. EMBO J 1994;14:1961-9.
11. Diaz-Meco MT, Municio MM, Sanchez P, Lozano J, Sanz L, Moscat J. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 1996;86:777-86.
12. Doornbos RP, Theelen M, van der Hoeven PC, van Blitterswijk WJ, Verkleij AJ, van Bergeb en Henegouwen PM. Protein kinase zeta is a negative regulator of protein kinase B activity. J Biol Chem 1999;274:8589-96.
13. Dramsi S, Scheid MP, Maiti A, Hojabrpour P, Chen X, Schubert K, Goodlett DR, Aebersold R, Duronio V. Identification of a novel phosphorylation site, Ser-70, as a regulator of bad pro-apoptotic activity. J Biol Chem 2002;277:6399-405.
14. Fang X, Yu S, Eder A, Mao M, Bast Jr, RC, Boyd D, Mills GB. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene 1999;18:6635-40.
15. Fernandez-Luna JL. Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells. Apoptosis 2000;5:315-8.
16. Filomenko R, Poirson-Bichat F, Billerey C, Belon Jean-Paul, Garrido C, Solary E, Bettaieb A. Atypical protein kinase C ζ as a target for chemosensitization of tumor cells. Cancer Res 2002;62:1815-21.
17. Folgueira L, McElhinny JA, Bren GD, MacMorran WS, Diaz-Meco MT, Moscat J, Paya CV. Protein kinase C-ζ mediates NF-κ B activation in human immunodeficiency virus-infected monocytes. J Virol 1996;70:223-31.
18. Gille H, Downward J. Multiple ras effector pathways contribute to G(1) cell cycle progression. J Biol Chem 1999;274:22033-40.
19. Gong JG, Constanzo A, Yang HQ, Melino G, Kaelin Jr, WG, Levero M, Wang JY. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999;399:806-9.
20. Groffen J, Stephenson JR, Heisterkamp N, deKlein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984;36:93-9.
21. Grossmann J. Molecular mechanisms of "detachment-induced apoptosis-Anoikis". Apoptosis 2002;7:247-60.
22. Grunicke HH. Protein kinase C. In: Schwab M, editor. Encyclopedic reference of cancer. Heidelberg: Springer, 2001. p. 728-32.
23. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
24. Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Murata Y. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-reduced protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res 2000;60:5988-94.
25. Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR, Grosveld G. Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelotic leukemia. Nature 1983;306:239-42.
26. Hofmann J. Modulation of protein kinase C in antitumor treatment. Rev Physiol Biochem 2001;142:1-96.
27. Jamieson L, Carpenter L, Biden TJ, Fields AP. Protein kinase Cι activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis. J Biol Chem 1999;274:3927-30.
28. Kampfer S, Hellbert K, Villunger A, Doppler W, Baier G, Grunicke HH, Ueberall F. Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta. EMBO J 1998;17:4046-55.
29. Kampfer S, Windegger M, Hochholdinger F, Schwaiger W, Pestell RG, Baier G, Grunicke HH, Ueberall F. Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras. J Biol Chem 2001;276:42834-42.
30. Karabanda S, Yuan ZM, Weichselbaum R, Kufe D. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene 1998;17:3309-18.
31. Keeshan K, Mills KI, Cotter TG, McKenna SL. Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype. Leukemia 2001;15:1823-33.
32. Kin Y, Shibuya M, Maru Y. Inhibition of protein kinase C δ has negative effect on anchorage-independent growth of BCR-ABL-transformed Rat 1 cells. Leuk Res 2001;25:821-5.
33. Kumar S, Bharti A, Mishra NC, Raina D, Kharbanda S, Saxena S, Kufe D. Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to oxidative stress. J Biol Chem 2001;276:17281-5.
34. Lallena MJ, Diaz-Meco MT, Bren G, Paya CV, Moscat J. Activation of IκB kinase β by protein kinase C isoforms. Mol Cell Biol 1999;19:2180-8.
35. Limatola C, Barbabino B, Nista A, Santoni A. Interleukin 1-β-induced protein kinase C-β activation is mimicked by exogenous phospholipase D. Biochem J 1997;321:497-501.
36. Limatola C, Schaap D, Moolenaar WH, van Blitterswijk WJ. Phosphatidic acid activation of protein kinase C-ζ overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids. Biochem J 1994;304:1001-8.
37. Lu Y, Jamieson L, Braiser AR, Fields AP. NF-κB/RelA transactivation is required for atypical protein kinase Cι-mediated cell survival. Oncogene 2001;20:4777-92.
38. Lu Z, Hornia A, Joseph T, Sukezanne T, Frankel P, Zhong M, Bychenok S, Xu L, Feig LA, Foster DA. Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts. Mol Cell Biol 2000;20:462-7.
39. Mabuchi S, Ohmichi M, Kimura A, Hisamoto K, Hayakawa J, Nishi Y, Adachi K, Takahashi K, Arimoto-Ishida E, Nakatsuzi Y, Tasaka K, Murata Y. Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to Paclixatel. J Biol Chem 2002 (epub ahead of print).
40. McConkey DJ, Orrenius S. Signal transduction pathways to apoptosis. Trends Cell Biol 1994;4:370-5.
41. Murray NR, Fields AP. Atypical protein kinase C ι protects human leukemia cells against drug-induced apoptosis. J Biol Chem 1997;272:27521-4.
42. Mwanjewe J, Spitaler M, Ebner M, Windegger M, Geiger M, Kampfer S, Hofmann J, Ueberall F, Grunicke H. Regulation of phospholipase D isoenzymes by transforming Ras and atypical protein kinase C-ι. J Biol Chem 2001;359:211-7.
43. Nakanishi H, Exton JH. Purification and characterization of the zeta isoform of protein kinase C from bovine kidney. J Biol Chem 1992;267:16347-54.
44. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 1998;92:3780-92.
45. Reed JC. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in haematologic malignancies. Semin Hematol 1997;34:9-19.
46. Rodriguez-Viciana P, Downward J. Ras activation of phosphatidylinositol 3-kinase and Akt. Methods Enzymol 2001;333:37-44.
47. Ron D, Kazanietz MG. New insights into the regulation of protein kinase C and novel phorpol ester receptors. FASEB 1999;13:1658-76.
48. Sanz L, Sanchez P, Lallena MJ, Diaz-Meco MT, Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J 1999;18:3044-53.
49. Shafman T, Khanna KK, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Watters D, Egerton M, Shiloh Y, Kharbanda S, Kufe S, Lavin MF. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 1997;387:450-1.
50. She QB, Ma WY, Zhong S, Dong Z. Activation of JNK1, RSK2, and MSK1 is involved in serine 112 phosphorylation of Bad by ultraviolet radiation. J Biol Chem 2002;277:24039-48.
51. Sionov RV, Coen S, Goldberg Z, Berger M, Bergcovich B, Ben-Neriah Y, Ciechanover A, Haupt Y. C-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Mol Cell Biol 2001;21:5869-78.
52. Sirard C, Laneuville P, Dick JE. Expression of BCR-ABL abrogates factor-dependent growth to human haematopoietic M07E cells by autocrine mechanism. Blood 1994;83:1575-85.
53. Spitaler M, Villunger A, Grunicke H, Ueberall F. Unique structural and functional properties of the ATP-binding domain of atypical protein kinase C-ι. J Biol Chem 2000;275:33289-96.
54. Sun X, Wu F, Datta R, Kharbanda S, Kufe D. Interaction between protein kinase C and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J Biol Chem 2000;275:7470-3.
55. Ueberall F, Giselbrecht S, Hellbert K, Fresser F, Bauer B, Gschwendt M, Grunicke HH, Baier G. Conventional PKC-α novel PKC-ε and PKC-θ, but not atypical PKC-λ are MARCKS kinases in intact NIH 3T3 fibroblasts. J Biol Chem 1997;272:4072-8.
56. Ueberall F, Hellbert K, Kampfer S, Maly K, Villunger A, Spitaler M, Mwanjewe J, Baier-Bitterlich G, Baier G, Grunicke HH. Evidence that atypical protein kinase C-λ and atypical protein kinase C-ζ participate in Ras-mediated reorganization of the F-actin cytoskeleton. J Cell Biol 1999;144:413-25.
57. Virdee K, Parone PA, Tolkovsky AM. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr Biol 2000;10:R883.
58. Voss M, Weernik PA, Haupenthal S, Moller U, Cool RH, Bauer B, Camonis JH, Jakobs KH, Schmidt M. Phospolipase D stimulation by receptor tyrosine kinases mediated by protein kinase C and a Ras/Ral signaling cascade. J Biol Chem 1999;274:34691-8.
59. Wang JY. Regulation of cell death by the Abl tyrosine kinase. Oncogene 2000;19:5643-50.
60. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995;80:285-91.
61. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosporylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X (L). Cell 1996;87:619-28.
62. Zhu G, Wang D, Lin YH, McMahon T, Koo EH, Messing RO. Protein kinase C ε suppresses Aβ production and promotes activation of α-secretase. Biochem Biophys Res Commun 2001;285:997-1006.